|Bid||0.0850 x N/A|
|Ask||0.0900 x N/A|
|Day's Range||0.0850 - 0.0900|
|52 Week Range||0.0800 - 0.2300|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Dec. 21, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Stigma Grow's new licences allow for the direct sale of cannabis extracts, including their expanding lineups of shatter, live resin vape cartridges, budders, waxes and more. RED DEER, AB, Dec.
RED DEER, AB, Dec. 7, 2020 /CNW/ - CANADABIS CAPITAL, (STIGMA GROW), (INDICAtive Collection), a National pioneer in cannabis concentrate production, research, cultivation and distribution, reports financial results for the fourth quarter and full fiscal year ended July 31, 2020.
CALGARY, AB / ACCESSWIRE / October 27, 2020 / This press release is being disseminated as required by National Instrument 62-103 -The Early Warning System and Take over Bid and Insider Reporting Issues regarding the disposition and acquisition of securities of CanadaBis Capital Inc.